Health Condition 1: J45- Asthma Health Condition 2: J453- Mild persistent asthma Health Condition 3: null- Patients of both sexes of 16 to 60 years with symptoms of Bronchial Asthma will be enrolled into the study
Conditions
Interventions
Intervention1: Shirishavaleha: Patients will receive 10 gm of Shirishavaleha twice a day for 28 days followed by lukewarm water as an adjuvant
In case of emergency, appropriate Bronchodilators, Corti
Sponsors
Institute for Post Graduate Teaching and Research in Ayurveda
Dept of AYSUH
Eligibility
Inclusion criteria
Inclusion criteria: Patients suffering with Mild persistent cases of Bronchial Asthma with daytime symptoms 3-6/week and nocturnal symptoms with 3-4/month and Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 weeks
Exclusion criteria
Exclusion criteria: Known patients of diabetes, dyspnoea resulting from cardiac origin, anaemia, age above 60 years and below 12 years, tuberculosis, malignancy and other chronic debilitating diseases, and patients who depend on regular use of inhalers will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in AEC and other haematological (TLC, DLC, Hb, AEC), Peak Expiratory Flow Rate and Breath Holding TimeTimepoint: Improvement in AEC and other haematological (TLC, DLC, Hb, AEC), Peak Expiratory Flow Rate and Breath Holding Time | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall improvement in the disease condition, Quality of Life of the diseased. Based on the observations, the study may be recommended to be added into the Essential Drugs List of Dept. of AYUSH, New DelhiTimepoint: 18 Months of Trial | — |
Countries
India
Contacts
Public ContactDr Galib
Institute for Post Graduate Teaching and Research in Ayurveda
Outcome results
None listed